Guangzhou Bio-gene Technology Co., Ltd
Clinical trials sponsored by Guangzhou Bio-gene Technology Co., Ltd, explained in plain language.
-
Exosome hair loss study halted early – what we know
Disease control TerminatedThis study tested whether exosomes from donated stem cells could help people with hair loss. It was a small, early-phase trial with 16 participants, comparing treated areas to untreated ones. The study was terminated early, so results are limited. The goal was to see if the treat…
Phase: EARLY_PHASE1 • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
CAR-T trial for blood cancer halted after single patient
Disease control TerminatedThis study tested a new CAR-T cell therapy for people with multiple myeloma that had come back or stopped responding to treatment. The therapy uses a patient's own immune cells to target cancer cells. The trial was stopped early and only enrolled one person, so we have very limit…
Phase: NA • Sponsor: Guangzhou Bio-gene Technology Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC